A Study Exploring the PK/PD Relationship of QRL-101 in Adults With ALS

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This Phase 1 randomized, placebo-controlled, double-blind study will evaluate the PK/PD relationship of single doses of QRL-101 in 12 ALS participants. The study will also assess safety and tolerability in participants receiving either QRL-101 or placebo.
Epistemonikos ID: 1736a4ce772a1207f19b77f377801d3958eaa71b
First added on: Jan 01, 2025